Literature DB >> 33383671

Omics Analysis of Educated Platelets in Cancer and Benign Disease of the Pancreas.

Giulia Mantini1,2, Laura L Meijer1,3, Ilias Glogovitis4,5, Sjors G J G In 't Veld4, Rosita Paleckyte1, Mjriam Capula2,6, Tessa Y S Le Large1,3, Luca Morelli7, Thang V Pham1, Sander R Piersma1, Adam E Frampton8,9, Connie R Jimenez1, Geert Kazemier3, Danijela Koppers-Lalic4, Thomas Wurdinger4, Elisa Giovannetti1,2.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is traditionally associated with thrombocytosis/hypercoagulation and novel insights on platelet-PDAC "dangerous liaisons" are warranted. Here we performed an integrative omics study investigating the biological processes of mRNAs and expressed miRNAs, as well as proteins in PDAC blood platelets, using benign disease as a reference for inflammatory noise. Gene ontology mining revealed enrichment of RNA splicing, mRNA processing and translation initiation in miRNAs and proteins but depletion in RNA transcripts. Remarkably, correlation analyses revealed a negative regulation on SPARC transcription by isomiRs involved in cancer signaling, suggesting a specific "education" in PDAC platelets. Platelets of benign patients were enriched for non-templated additions of G nucleotides (#ntaG) miRNAs, while PDAC presented length variation on 3' (lv3p) as the most frequent modification on miRNAs. Additionally, we provided an actionable repertoire of PDAC and benign platelet-ome to be exploited for future studies. In conclusion, our data show that platelets change their biological repertoire in patients with PDAC, through dysregulation of miRNAs and splicing factors, supporting the presence of de novo protein machinery that can "educate" the platelet. These novel findings could be further exploited for innovative liquid biopsies platforms as well as possible therapeutic targets.

Entities:  

Keywords:  gene expression; liquid biopsy; miRNAs; omics integration; pancreatic cancer; platelets; proteins; regulatory mechanisms

Year:  2020        PMID: 33383671     DOI: 10.3390/cancers13010066

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  7 in total

1.  Oncogenic KRAS-Induced Protein Signature in the Tumor Secretome Identifies Laminin-C2 and Pentraxin-3 as Useful Biomarkers for the Early Diagnosis of Pancreatic Cancer.

Authors:  Mohammad Azhar Kamal; Imran Siddiqui; Cristina Belgiovine; Marialuisa Barbagallo; Valentina Paleari; Daniela Pistillo; Chiara Chiabrando; Silvia Schiarea; Barbara Bottazzi; Roberto Leone; Roberta Avigni; Roberta Migliore; Paola Spaggiari; Francesca Gavazzi; Giovanni Capretti; Federica Marchesi; Alberto Mantovani; Alessandro Zerbi; Paola Allavena
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

Review 2.  Challenges and Opportunities Associated With Platelets in Pancreatic Cancer.

Authors:  Zhou Chen; Xiaodong Wei; Shi Dong; Fangfang Han; Ru He; Wence Zhou
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

3.  Novel Strategies to Address Critical Challenges in Pancreatic Cancer.

Authors:  Jisce R Puik; Rutger-Jan Swijnenburg; Geert Kazemier; Elisa Giovannetti
Journal:  Cancers (Basel)       Date:  2022-08-25       Impact factor: 6.575

4.  Overexpressed Thrombospondin 2 Induced Osteogenic Differentiation of Valve Interstitial Cells via Inhibition of Akt/NF-κB Signaling Pathway to Promote Calcific Aortic Valve Disease Development.

Authors:  Cheng Yu; Danna Wu; Chong Zhao; Chaoguang Wu
Journal:  Dis Markers       Date:  2022-09-08       Impact factor: 3.464

Review 5.  Platelet detection as a new liquid biopsy tool for human cancers.

Authors:  Maoshan Chen; Lijia Hou; Lanyue Hu; Chengning Tan; Xiaojie Wang; Peipei Bao; Qian Ran; Li Chen; Zhongjun Li
Journal:  Front Oncol       Date:  2022-09-14       Impact factor: 5.738

6.  The Diagnostic Value of the CA19-9 and Bilirubin Ratio in Patients with Pancreatic Cancer, Distal Bile Duct Cancer and Benign Periampullary Diseases, a Novel Approach.

Authors:  Lenka N C Boyd; Mahsoem Ali; Laura Kam; Jisce R Puik; Stephanie M Fraga Rodrigues; Eline S Zwart; Freek Daams; Barbara M Zonderhuis; Laura L Meijer; Tessa Y S Le Large; Elisa Giovannetti; Hanneke W M van Laarhoven; Geert Kazemier
Journal:  Cancers (Basel)       Date:  2022-01-11       Impact factor: 6.639

7.  imPlatelet classifier: image-converted RNA biomarker profiles enable blood-based cancer diagnostics.

Authors:  Krzysztof Pastuszak; Anna Supernat; Myron G Best; Sjors G J G In 't Veld; Sylwia Łapińska-Szumczyk; Anna Łojkowska; Robert Różański; Anna J Żaczek; Jacek Jassem; Thomas Würdinger; Tomasz Stokowy
Journal:  Mol Oncol       Date:  2021-06-20       Impact factor: 6.603

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.